Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Ann Surg Oncol
    September 2017
  1. GENTILE LF, Plitas G, Zabor EC, Stempel M, et al
    Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2017 Sep 15. doi: 10.1245/s10434-017-6085.
    >> Share

  2. ZHANG Y, Seely J, Cordeiro E, Hefler J, et al
    Radioactive Seed Localization Versus Wire-Guided Localization for Nonpalpable Breast Cancer: A Cost and Operating Room Efficiency Analysis.
    Ann Surg Oncol. 2017 Sep 14. doi: 10.1245/s10434-017-6084.
    >> Share

  3. MCLAUGHLIN SA, Cornell LF, Mussallem DM
    Sexual Function and Breast-Specific Sensuality Remain Important After Breast Cancer Surgery.
    Ann Surg Oncol. 2017 Sep 13. doi: 10.1245/s10434-017-6086.
    >> Share

  4. DONOVAN CA, Giuliano AE
    Evolution of the Staging System in Breast Cancer.
    Ann Surg Oncol. 2017 Sep 8. doi: 10.1245/s10434-017-6035.
    >> Share

  5. ONG CT, Thomas SM, Blitzblau RC, Fayanju OM, et al
    Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.
    Ann Surg Oncol. 2017 Sep 6. doi: 10.1245/s10434-017-6075.
    >> Share

    August 2017
  6. SONG Z, Ye T, Ma L, Xiang J, et al
    Surgical Outcomes of Isolated Malignant Pulmonary Nodules in Patients with a History of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 28. doi: 10.1245/s10434-017-6067.
    >> Share

  7. BERGQUIST JR, Murphy BL, Storlie CB, Habermann EB, et al
    Incorporation of Treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2017 Aug 21. doi: 10.1245/s10434-017-6010.
    >> Share

  8. NGUYEN TT, Hieken TJ, Glazebrook KN, Boughey JC, et al
    Localizing the Clipped Node in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Early Learning Experience and Challenges.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-6023.
    >> Share

  9. MCLAUGHLIN SA, Staley AC, Vicini F, Thiruchelvam P, et al
    Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5982.
    >> Share

  10. KIM SY, Kawaguchi T, Yan L, Young J, et al
    Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5984.
    >> Share

  11. NGUYEN TT, Hoskin TL, Habermann EB, Cheville AL, et al
    Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5960.
    >> Share

  12. MENDEZ J, Boughey JC
    Changing Dogma and Decreased Collateral Damage in Breast Cancer Care.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5937.
    >> Share

  13. NEWMAN LA
    Breast Cancer Disparities: Socioeconomic Factors versus Biology.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5977.
    >> Share

  14. ROSSO KJ, Tadros AB, Weiss A, Warneke CL, et al
    Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5952.
    >> Share

  15. MCLAUGHLIN SA, DeSnyder SM, Klimberg S, Alatriste M, et al
    Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5964.
    >> Share

  16. ELDER EA, Ferlin A, Vallow LA, Li Z, et al
    The Influence of Breast Density on Preoperative MRI Findings and Outcome in Patients with a Known Diagnosis of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5981.
    >> Share

  17. O'LEARY E, Iacoboni D, Holle J, Michalski ST, et al
    Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5963.
    >> Share

  18. MUSTAFA RE, DeStefano LM, Bahng J, Yoon-Flannery K, et al
    Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5941.
    >> Share

  19. SILVERSTEIN MJ, Epstein MS, Lin K, Chen P, et al
    Intraoperative Radiation Using Low-Kilovoltage X-Rays for Early Breast Cancer: A Single Site Trial.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5934.
    >> Share

  20. HARRIS CK, Tran HT, Lee K, Mylander C, et al
    Positive Ultrasound-guided Lymph Node Needle Biopsy in Breast Cancer may not Mandate Axillary Lymph Node Dissection.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5935.
    >> Share

  21. SCHUMACHER JR, Taylor LJ, Tucholka JL, Poore S, et al
    Socioeconomic Factors Associated with Post-Mastectomy Immediate Reconstruction in a Contemporary Cohort of Breast Cancer Survivors.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5933.
    >> Share

  22. MILLER ME, Muhsen S, Olcese C, Patil S, et al
    Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5931.
    >> Share

  23. CAUDLE AS, Bedrosian I, Milton DR, DeSnyder SM, et al
    Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5958.
    >> Share

  24. KUERER HM, Vrancken Peeters MTFD, Rea DW, Basik M, et al
    Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5926.
    >> Share

  25. MURPHY AE, Hussain L, Ho C, Dunki-Jacobs E, et al
    Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5957.
    >> Share

  26. WENZ F
    Keynote Address at the American Society of Breast Surgeons 18th Annual Meeting : Current and Future Application of Intraoperative Radiotherapy (IORT) in the Curative and Palliative Treatment of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5942.
    >> Share

  27. HESSLER LK, Molitoris JK, Rosenblatt PY, Bellavance EC, et al
    Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5928.
    >> Share

  28. WELSH JL, Hoskin TL, Day CN, Habermann EB, et al
    Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5932.
    >> Share

  29. CHAGPAR AB, Hatzis C, Pusztai L, DiGiovanna MP, et al
    Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5936.
    >> Share

    July 2017
  30. PILEWSKIE M, Zabor EC, Mamtani A, Barrio AV, et al
    The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.
    Ann Surg Oncol. 2017 Jul 31. doi: 10.1245/s10434-017-6016.
    >> Share

  31. O'NEILL AC, Zhong T, Hofer SOP
    Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
    Ann Surg Oncol. 2017 Jul 31. doi: 10.1245/s10434-017-6014.
    >> Share

  32. MCGUIRE A, Lowery AJ, Kell MR, Kerin MJ, et al
    Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype.
    Ann Surg Oncol. 2017 Jul 28. doi: 10.1245/s10434-017-6021.
    >> Share

  33. SHUMWAY DA, Griffith KA, Sabel MS, Jones RD, et al
    Surgeon and Radiation Oncologist Views on Omission of Adjuvant Radiotherapy for Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2017 Jul 26. doi: 10.1245/s10434-017-6013.
    >> Share

  34. CHANG YC, Chen CK, Chen MJ, Lin JC, et al
    Expression of 3beta-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status.
    Ann Surg Oncol. 2017 Jul 25. doi: 10.1245/s10434-017-6000.
    >> Share

  35. WAHNER HENDRICKSON AE, Bakkum-Gamez JN, J Couch F, Ghosh K, et al
    Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
    Ann Surg Oncol. 2017 Jul 20. doi: 10.1245/s10434-017-5999.
    >> Share

  36. MITTENDORF EA, Chavez-MacGregor M, Vila J, Yi M, et al
    Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.
    Ann Surg Oncol. 2017 Jul 19. doi: 10.1245/s10434-017-6009.
    >> Share

  37. MAMTANI A, Patil S, Stempel M, Morrow M, et al
    Erratum to: Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.
    Ann Surg Oncol. 2017 Jul 17. doi: 10.1245/s10434-017-6004.
    >> Share

  38. MCCARTAN DP, Zabor EC, Morrow M, Van Zee KJ, et al
    Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).
    Ann Surg Oncol. 2017 Jul 12. doi: 10.1245/s10434-017-5965.
    >> Share

  39. AJMANI GS, James TA, Kantor O, Wang CH, et al
    The Impact of Facility Volume on Rates for Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer.
    Ann Surg Oncol. 2017 Jul 6. doi: 10.1245/s10434-017-5969.
    >> Share

    June 2017
  40. PARK MH, Kwon HJ, Kim JR, Lee B, et al
    Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer.
    Ann Surg Oncol. 2017 Jun 20. doi: 10.1245/s10434-017-5907.
    >> Share

  41. TSANG JYS, Chan KW, Ni YB, Hlaing T, et al
    Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer.
    Ann Surg Oncol. 2017 Jun 13. doi: 10.1245/s10434-017-5924.
    >> Share

    May 2017
  42. NAKHLIS F, Regan MM, Warren LE, Bellon JR, et al
    The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5903.
    >> Share

  43. CORNELL LF, Mussallem DM, Gibson TC, Diehl NN, et al
    Trends in Sexual Function After Breast Cancer Surgery.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5894.
    >> Share

  44. MURPHY BL, L Hoskin T, Heins CDN, Habermann EB, et al
    Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer.
    Ann Surg Oncol. 2017 May 8. doi: 10.1245/s10434-017-5872.
    >> Share

    April 2017
  45. WONG SM, King T, Boileau JF, Barry WT, et al
    Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Ann Surg Oncol. 2017 Apr 28. doi: 10.1245/s10434-017-5867.
    >> Share

  46. BEITSCH P, Whitworth P, Baron P, Rotkis MC, et al
    Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
    Ann Surg Oncol. 2017 Apr 26. doi: 10.1245/s10434-017-5863.
    >> Share

  47. SONG BI, Kim HW, Won KS
    Predictive Value of 18F-FDG PET/CT for Axillary Lymph Node Metastasis in Invasive Ductal Breast Cancer.
    Ann Surg Oncol. 2017 Apr 21. doi: 10.1245/s10434-017-5860.
    >> Share

  48. MAMTANI A, Patil S, Stempel M, Morrow M, et al
    Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.
    Ann Surg Oncol. 2017 Apr 20. doi: 10.1245/s10434-017-5866.
    >> Share

  49. DONOVAN CA, Bao J, Gangi A, Amersi F, et al
    Bilateral Mastectomy as Overtreatment for Breast Cancer in Women Age Forty Years and Younger with Unilateral Operable Invasive Breast Cancer.
    Ann Surg Oncol. 2017 Apr 17. doi: 10.1245/s10434-017-5856.
    >> Share

    March 2017
  50. ZHU L, Chen K, Jacobs LK, Aft R, et al
    Axillary Lymphadenectomy in Sentinel Lymph Node-Positive Breast Cancer.
    Ann Surg Oncol. 2017 Mar 31. doi: 10.1245/s10434-017-5849.
    >> Share

  51. MORROW M, Hawley ST, McLeod MC, Hamilton AS, et al
    Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer.
    Ann Surg Oncol. 2017 Mar 22. doi: 10.1245/s10434-017-5840.
    >> Share

  52. TRAVIS CLIFTON G, Litton JK, Arrington K, Ponniah S, et al
    Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+ T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients.
    Ann Surg Oncol. 2017 Mar 17. doi: 10.1245/s10434-017-5844.
    >> Share

    February 2017
  53. WADE RG, Razzano S, Sassoon EM, Haywood RM, et al
    Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions.
    Ann Surg Oncol. 2017 Feb 22. doi: 10.1245/s10434-017-5807.
    >> Share

  54. SCHAVERIEN MV, Butler CE
    Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral and Bilateral Reconstructions.
    Ann Surg Oncol. 2017 Feb 13. doi: 10.1245/s10434-017-5809.
    >> Share

  55. LIANG Y, Chen X, Zhan W, Garfield DH, et al
    Can Clinically Node-Negative Breast Cancer Patients with Suspicious Axillary Lymph Nodes at Ultrasound But Negative Fine-Needle Aspiration Be Approached as Having Node-Negative Disease?
    Ann Surg Oncol. 2017 Feb 6. doi: 10.1245/s10434-017-5798.
    >> Share

  56. TEN WOLDE B, Kuiper M, de Wilt JH, Strobbe LJ, et al
    Postoperative Complications After Breast Cancer Surgery are Not Related to Age.
    Ann Surg Oncol. 2017 Feb 6. doi: 10.1245/s10434-016-5726.
    >> Share

  57. CHEN HA, Chang YW, Tseng CF, Chiu CF, et al
    Erratum to: E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2017 Feb 3. doi: 10.1245/s10434-017-5769.
    >> Share

    January 2017
  58. SCHWARTZ TL, Margenthaler JA
    Axillary Ultrasound Before Neoadjuvant Chemotherapy for Breast Cancer: Don't Discount the Benefits Yet!
    Ann Surg Oncol. 2017 Jan 17. doi: 10.1245/s10434-017-5766.
    >> Share

  59. LANDERCASPER J, Bennie B, Parsons BM, Dietrich LL, et al
    Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database.
    Ann Surg Oncol. 2017 Jan 6. doi: 10.1245/s10434-016-5760.
    >> Share

  60. FELICIANO Y, Mamtani A, Morrow M, Stempel MM, et al
    Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?
    Ann Surg Oncol. 2017 Jan 5. doi: 10.1245/s10434-016-5741.
    >> Share

  61. BOUGHEY JC, Haffty BG, Habermann EB, Hoskin TL, et al
    Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?
    Ann Surg Oncol. 2017 Jan 4. doi: 10.1245/s10434-016-5740.
    >> Share

    December 2016
  62. PUIG CA, Hoskin TL, Day CN, Habermann EB, et al
    National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.
    Ann Surg Oncol. 2016 Dec 20. doi: 10.1245/s10434-016-5733.
    >> Share

    November 2016
  63. BEAR HD, Tang G, Rastogi P, Geyer CE Jr, et al
    The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
    Ann Surg Oncol. 2016.
    >> Share

  64. RAKHRA S, Bethke K, Strauss J, Hayes JP, et al
    Risk Factors Leading to Complications in Early-Stage Breast Cancer Following Breast-Conserving Surgery and Intraoperative Radiotherapy.
    Ann Surg Oncol. 2016.
    >> Share

  65. DE LA CRUZ LM, McDonald ES, Mick R, Datta J, et al
    Anti-HER2 CD4+ T-Helper Type 1 Immune Response is Superior to Breast MRI for Assessing Response to Neoadjuvant Therapy in Patients with HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  66. MATEO AM, Pezzi TA, Sundermeyer M, Kelley CA, et al
    Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base.
    Ann Surg Oncol. 2016.
    >> Share

    October 2016
  67. RADOSA JC, Eaton A, Stempel M, Khander A, et al
    Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age.
    Ann Surg Oncol. 2016.
    >> Share

  68. WHITWORTH P, Beitsch P, Mislowsky A, Pellicane JV, et al
    Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping.
    Ann Surg Oncol. 2016.
    >> Share

  69. GRATZON A, Schultz J, Secrest K, Lee K, et al
    Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy.
    Ann Surg Oncol. 2016.
    >> Share

  70. NEUMAN HB, Schumacher JR, Schneider DF, Winslow ER, et al
    Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis.
    Ann Surg Oncol. 2016.
    >> Share

  71. FITZSULLIVAN E, Bassett RL, Kuerer HM, Mittendorf EA, et al
    Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.
    Ann Surg Oncol. 2016.
    >> Share

    September 2016
  72. CHIBA A, Hoskin TL, Heins CN, Hunt KK, et al
    Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study.
    Ann Surg Oncol. 2016.
    >> Share

  73. MOGAL HD, Clark C, Dodson R, Fino NF, et al
    Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  74. FLAHERTY DC, Bawa R, Burton C, Goldfarb M, et al
    Breast Cancer in Male Adolescents and Young Adults.
    Ann Surg Oncol. 2016.
    >> Share

    August 2016
  75. SCHULMAN AM, Mirrielees JA, Leverson G, Landercasper J, et al
    Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) MasterySM Database Following the SSO-ASTRO "No Ink on Tumor" Guidelines.
    Ann Surg Oncol. 2016.
    >> Share

  76. RUIZ A, Wicherts DA, Sebagh M, Giacchetti S, et al
    Predictive Profile-Nomogram for Liver Resection for Breast Cancer Metastases: An Aggressive Approach with Promising Results.
    Ann Surg Oncol. 2016.
    >> Share

  77. SHAH C, Tendulkar R, Smile T, Nanavati A, et al
    Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options.
    Ann Surg Oncol. 2016.
    >> Share

  78. MCCRAY DK, Simpson AB, Flyckt R, Liu Y, et al
    Erratum to: Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and Outcomes.
    Ann Surg Oncol. 2016.
    >> Share

  79. POLVERINI AC, Nelson RA, Marcinkowski E, Jones VC, et al
    Time to Treatment: Measuring Quality Breast Cancer Care.
    Ann Surg Oncol. 2016.
    >> Share

  80. NEUMAN HB, Schumacher JR, Francescatti AB, Adesoye T, et al
    Utility of Clinical Breast Examinations in Detecting Local-Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  81. PARIKH RP, Sharma K, Guffey R, Myckatyn TM, et al
    Preoperative Paravertebral Block Improves Postoperative Pain Control and Reduces Hospital Length of Stay in Patients Undergoing Autologous Breast Reconstruction after Mastectomy for Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

    July 2016
  82. JIAGGE E, Jibril AS, Chitale D, Bensenhaver JM, et al
    Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  83. WARREN LE, Ligibel JA, Chen YH, Truong L, et al
    Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  84. DIXON JM
    Sentinel Lymph Node Biopsy in Breast Cancer Surgery.
    Ann Surg Oncol. 2016.
    >> Share

  85. JAMES TA, Coffman AR, Chagpar AB, Boughey JC, et al
    Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery.
    Ann Surg Oncol. 2016.
    >> Share

  86. HIEKEN TJ, Mutter RW, Jakub JW, Boughey JC, et al
    Erratum to: A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  87. LAI SF, Chen YH, Kuo WH, Lien HC, et al
    Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy.
    Ann Surg Oncol. 2016.
    >> Share

  88. GASS J, Dupree B, Pruthi S, Radford D, et al
    Breast Cancer Survivorship: Why, What and When?
    Ann Surg Oncol. 2016.
    >> Share

  89. OBENG-GYASI S, Tolnitch L, Greenup RA, Shelley Hwang E, et al
    The Impact of the Affordable Care Act on North Carolinian Breast Cancer Patients Seeking Financial Support for Treatment.
    Ann Surg Oncol. 2016.
    >> Share

  90. PLICHTA JK, Rai U, Tang R, Coopey SB, et al
    Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger.
    Ann Surg Oncol. 2016.
    >> Share

  91. CARTER SA, Lyons GR, Kuerer HM, Bassett RL Jr, et al
    Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction.
    Ann Surg Oncol. 2016.
    >> Share

  92. BOUGHEY JC, Dietz JR
    Editorial: Management Based on Risk: Individualizing the Care of the Breast Cancer Patient.
    Ann Surg Oncol. 2016.
    >> Share

  93. ROSENBERGER LH, Mamtani A, Fuzesi S, Stempel M, et al
    Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.
    Ann Surg Oncol. 2016.
    >> Share

  94. CLIFFORD E, Hughes KS, Roberts M, Pirzadeh-Miller S, et al
    Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  95. TSAI J, Bertoni D, Hernandez-Boussard T, Telli ML, et al
    Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  96. BEITSCH P, Whitworth P, Baron P, Pellicane J, et al
    Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures.
    Ann Surg Oncol. 2016.
    >> Share

    June 2016
  97. KWAIT RM, Pesek S, Onstad M, Edmonson D, et al
    Influential Forces in Breast Cancer Surgical Decision Making and the Impact on Body Image and Sexual Function.
    Ann Surg Oncol. 2016.
    >> Share

  98. MAMTANI A, Gonzalez JJ, Neo D, Slanetz PJ, et al
    Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes.
    Ann Surg Oncol. 2016.
    >> Share

  99. MURPHY BL, Hoskin TL, Boughey JC, Degnim AC, et al
    Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  100. KUERER HM, van la Parra RF
    Breast Cancer Clinical Trials: Past Half Century Moving Forward Advancing Patient Outcomes.
    Ann Surg Oncol. 2016.
    >> Share

  101. DE LA CRUZ L, Blankenship SA, Chatterjee A, Geha R, et al
    Outcomes After Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients: A Systematic Literature Review.
    Ann Surg Oncol. 2016.
    >> Share

  102. TSAO MW, Cornacchi SD, Hodgson N, Simunovic M, et al
    A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  103. MCCARTAN D, Stempel M, Eaton A, Morrow M, et al
    Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer Patients.
    Ann Surg Oncol. 2016.
    >> Share

  104. CHIBA A, Hoskin TL, Hallberg EJ, Cogswell JA, et al
    Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  105. MCCRAY DK, Simpson AB, Flykct R, Liu Y, et al
    Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and Outcomes.
    Ann Surg Oncol. 2016.
    >> Share

  106. HIEKEN TJ, Mutter RM, Jakub JW, Boughey JC, et al
    A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  107. PAIRAWAN SS, Cora C, Olaya W, Deisch J, et al
    Percutaneous Sentinel Node Biopsy in Breast Cancer: Results of a Phase 1 Study.
    Ann Surg Oncol. 2016.
    >> Share

  108. EPSTEIN M, Silverstein M, Lin K, Kim B, et al
    Acute and Chronic Complications in Breast Cancer Patients Treated with Intraoperative Radiation Therapy.
    Ann Surg Oncol. 2016.
    >> Share

  109. LAI L, Binkley J, Jones V, Kirkpatrick S, et al
    Implementing the Prospective Surveillance Model (PSM) of Rehabilitation for Breast Cancer Patients with 1-Year Postoperative Follow-up, a Prospective, Observational Study.
    Ann Surg Oncol. 2016.
    >> Share

  110. ABDELSATTAR JM, Al-Hilli Z, Hoskin TL, Heins CN, et al
    Validation of the CPS + EG Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2016.
    >> Share

  111. MASSIMINO KP, Jochelson MS, Burgan IE, Stempel M, et al
    How Beneficial is Follow-Up Mammography in Elderly Breast Cancer Survivors?
    Ann Surg Oncol. 2016.
    >> Share

  112. ATTAI DJ, Hampton R, Staley AC, Borgert A, et al
    What Do Patients Prefer? Understanding Patient Perspectives on Receiving a New Breast Cancer Diagnosis.
    Ann Surg Oncol. 2016.
    >> Share

  113. MAMOUNAS E, Poulos C, Goertz HP, Gonzalez JM, et al
    Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals.
    Ann Surg Oncol. 2016.
    >> Share

  114. KIM MC, Choi JE, Lee SJ, Bae YK, et al
    Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

    May 2016
  115. VILA J, Mittendorf EA, Farante G, Bassett RL, et al
    Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  116. TAN MP
    Is there an Ideal Breast Conservation Rate for the Treatment of Breast Cancer?
    Ann Surg Oncol. 2016.
    >> Share

  117. MINAMI CA, Bilimoria KY, Hansen NM, Strauss JB, et al
    National Evaluation of the New Commission on Cancer Quality Measure for Postmastectomy Radiation Treatment for Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  118. VALENTE SA, Tendulkar RD, Cherian S, O'Rourke C, et al
    TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer.
    Ann Surg Oncol. 2016.
    >> Share

  119. BLAIR SL
    A New Technology for Sentinel Node Biopsy: A Logistic Improvement.
    Ann Surg Oncol. 2016;23:1418-9.
    >> Share

    March 2016
  120. JOHNSON J, Esserman L, Ewing C, Alvarado M, et al
    Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
    Ann Surg Oncol. 2016;23:715-21.
    >> Share

  121. MATTOS D, Gfrerer L, Ling IT, Reish RG, et al
    Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.
    Ann Surg Oncol. 2016;23:767-75.
    >> Share

  122. NAKHLIS F, Gilmore L, Gelman R, Bedrosian I, et al
    Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
    Ann Surg Oncol. 2016;23:722-8.
    >> Share

  123. JEFFE DB, Perez M, Cole EF, Liu Y, et al
    The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up.
    Ann Surg Oncol. 2016;23:735-43.
    >> Share

  124. SWISHER SK, Vila J, Tucker SL, Bedrosian I, et al
    Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.
    Ann Surg Oncol. 2016;23:749-56.
    >> Share

  125. MA XP, Wang W, Kong Y, Ren Y, et al
    A Novel Light-Emitting Wire Enhances the Marking and Visualization of Pathologic Mammary Ducts During Selective Microdochectomy.
    Ann Surg Oncol. 2016;23:796-800.
    >> Share

  126. NEUMAN HB, Steffens NM, Jacobson N, Tevaarwerk A, et al
    Oncologists' Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up.
    Ann Surg Oncol. 2016;23:708-14.
    >> Share

  127. EDWARDS BL, Guidry CA, Larson KN, Novicoff WM, et al
    Does Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?
    Ann Surg Oncol. 2016;23:782-8.
    >> Share

  128. MESTAK O, Hromadkova V, Fajfrova M, Molitor M, et al
    Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study.
    Ann Surg Oncol. 2016;23:776-81.
    >> Share

  129. MERRILL AL, Coopey SB, Tang R, McEvoy MP, et al
    Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Ann Surg Oncol. 2016;23:729-34.
    >> Share

  130. SCHAEFGEN B, Mati M, Sinn HP, Golatta M, et al
    Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?
    Ann Surg Oncol. 2016;23:789-95.
    >> Share

  131. STEFANOVIC S, Diel I, Sinn P, Englert S, et al
    Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment.
    Ann Surg Oncol. 2016;23:757-66.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016